Shareholders of Canada's largest dental clinic operator approve the acquisition deal, and the transa

*Source of image: Dentalcorp official website

Good Teeth News |Dentalcorp (TSX: DNTL), the largest dental clinic network operator in Canada, recently announced that at the company's special general meeting of shareholders, shareholders approved the previously announced acquisition arrangement resolution, agreeing that an affiliated investment fund of GTCR LLC will acquire all of the company's issued and outstanding shares at a cash price of C$11 per share.

The voting results show that the Shareholder Vote passed with 92.42% support, the Securityholder Vote passed with 92.60% support, the SVS Vote passed with 88.48% support, the MVS Vote passed with 100% support, and the Majority - of - Minority Vote passed with 88.21% support.

According to a previous report by Good Teeth, the transaction was first announced on September 26, 2025. The equity value of Dentalcorp in the transaction is estimated to be approximately C$2.2 billion (approximately RMB 11.3 billion), and the enterprise value reaches C$3.3 billion (approximately RMB 16.9 billion).

According to the company's disclosure, shareholders such as founder and CEO Graham Rosenberg, president and CFO Nate Tchaplia, and investor L Catterton have chosen to convert some of their shares into equity of the post - acquisition entity, and the remaining shares will be exchanged for cash at C$11 per share. All share conversions will be carried out at the cash acquisition price.

The completion of the transaction is still subject to other conditions, including obtaining a final approval order from the Supreme Court of British Columbia and approval under the Investment Canada Act. The transaction is expected to be completed in the first quarter of 2026.

According to Dentalcorp's financial report for the third quarter of 2025, the company achieved revenue of C$420 million (approximately RMB 2.1 billion) in the third quarter, a year - on - year increase of 11.9%; the cumulative revenue in the first three quarters was C$1.265 billion (approximately RMB 6.4 billion), a year - on - year increase of 10.2%. As of the end of the third quarter, the company's operating network had expanded to 590 clinics.